drugset

drugset / Trial / NCT04137198

Sufentanil Intranasal

NCT04137198 ↗

Phase 4 Unknown 170 enrolled Centre Hospitalier Universitaire Saint Pierre

RandomizedParallel-groupOpen-labelTreatment

Summary

Study of the effects of intranasal sufentanil on patients presenting to the emergency department with acute post-traumatic pain.

Timeline

Start: 2020-01-22
Primary completion: 2025-07-30
Completion: 2025-09-01

Publications

Malinverni S, Kreps B, Lucaccioni T, Bouazza FZ, Bartiaux M, Plumacker A, Pascu A, Youatou Towo P. Effect of intranasal sufentanil on acute post-traumatic pain in the emergency department: a randomised controlled trial. Emerg Med J. 2024 Jan 22;41(2):83-88. doi: 10.1136/emermed-2023-213353.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sufentanil	Other / unclassified	0.3 ug/kg	Intranasal

Indications

No indication recorded.